Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1844, Issue 9, 2014, Pages 1481-1485

  Liu, Yanqin ^a   Carver, John A ^b   Calabrese, Antonio N ^a   Pukala, Tara L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Amyloid fibril; Gallic acid; Ion mobility mass spectrometry; NMR spectroscopy; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; GALLIC ACID; ION; THIOFLAVINE;

ARTICLE; CONFORMATIONAL TRANSITION; DRUG INHIBITION; FLUORESCENCE ANALYSIS; IN VITRO STUDY; ION MOBILITY MASS SPECTROMETRY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; STRUCTURE COLLAPSE; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID FIBRIL; GALLIC ACID; ION MOBILITY MASS SPECTROMETRY; NMR SPECTROSCOPY; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; AMYLOID; FLOCCULATION; FLUORESCENT DYES; GALLIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, TRANSMISSION; PROTEIN BINDING; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; THIAZOLES;

EID: 84902163020     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2014.04.013     Document Type: Article

References (54)

1. M.R. Cookson The biochemistry of Parkinson's disease Annu. Rev. Biochem. 74 2005 29 52 (Pubitemid 40995500)
2. P.E. Duffy, and V.M. Tennyson Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson's disease J. Neuropathol. Exp. Neurol. 24 1965 398 414
3. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
4. E. Colla, H. Jensen, O. Pletnikova, J.C. Troncoso, C. Glabe, and M.K. Lee Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo J. Neurosci. 32 2012 3301 3305
5. B. Winner, R. Jappelli, S.K. Maji, P.A. Desplats, L. Boyer, S. Aigner, C. Hetzer, T. Loher, M. Vilar, S. Campioni, C. Tzitzilonis, A. Soragni, S. Jessberger, H. Mira, A. Consiglio, E. Pham, E. Masliah, F.H. Gage, and R. Riek In vivo demonstration that alpha-synuclein oligomers are toxic Proc. Natl. Acad. Sci. U. S. A. 108 2011 4194 4199
6. A.M. Bodles, O.M. El-Agnaf, B. Greer, D.J. Guthrie, and G.B. Irvine Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue Neurosci. Lett. 359 2004 89 93 (Pubitemid 38446646)
7. C.A. Waudby, T.P. Knowles, G.L. Devlin, J.N. Skepper, H. Ecroyd, J.A. Carver, M.E. Welland, J. Christodoulou, C.M. Dobson, and S. Meehan The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation Biophys. J. 98 2010 843 851
8. T.F. Outeiro, J. Klucken, K.E. Strathearn, F. Liu, P. Nguyen, J.C. Rochet, B.T. Hyman, and P.J. McLean Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation Biochem. Biophys. Res. Commun. 351 2006 631 638 (Pubitemid 44780855)
9. S.R. Hughes, O. Khorkova, S. Goyal, J. Knaeblein, J. Heroux, N.G. Riedel, and S. Sahasrabudhe Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation Proc. Natl. Acad. Sci. U. S. A. 95 1998 3275 3280 (Pubitemid 28135892)
10. Abdullah Sultan, Ch. Raman Bakthisaran, Mohan Rao, and Ramakrishna Tangirala The extracellular chaperone haptoglobin prevents serum fatty acid-promoted amyloid fibril formation of beta2-microglobulin, resistance to lysosomal degradation, and cytotoxicity J. Biol. Chem. 288 2013 32326 32342
11. Y. Kiuchi, Y. Isobe, and K. Fukushima Type IV collagen prevents amyloid beta-protein fibril formation Life Sci. 70 2002 1555 1564 (Pubitemid 34164549)
12. I.R. Chandrashekaran, C.G. Adda, C.A. MacRaild, R.F. Anders, and R.S. Norton Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2 Biochemistry 49 2010 5899 5908
13. Y.M. Lin, R. Raffen, Y. Zhou, C.S. Cassidy, M.T. Flavin, and F.J. Stevens Amyloid fibril formation in microwell plates for screening of inhibitors Amyloid 8 2001 182 193 (Pubitemid 32911604)
14. M. Hirohata, K. Hasegawa, S. Tsutsumi-Yasuhara, Y. Ohhashi, T. Ookoshi, K. Ono, M. Yamada, and H. Naiki The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure Biochemistry 46 2007 1888 1899
15. S.A. Hudson, H. Ecroyd, F.C. Dehle, I.F. Musgrave, and J.A. Carver (-)-Epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway J. Mol. Biol. 392 2009 689 700
16. I.J. Kang, Y.E. Jeon, X.F. Yin, J.S. Nam, S.G. You, M.S. Hong, B.G. Jang, and M.J. Kim Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death Food Chem. Toxicol. 49 2011 2252 2259
17. Y. Feng, X.P. Wang, S.G. Yang, Y.J. Wang, and X. Zhang Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation Neurotoxicology 30 2009 986 995
18. K. Raina, S. Rajamanickam, G. Deep, M. Singh, R. Agarwal, and C. Agarwal Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice Mol. Cancer Ther. 7 2008 1258 1267
19. Y. Ohno, K. Fukuda, G. Takemura, M. Toyota, M. Watanabe, N. Yasuda, Q. Xinbin, R. Maruyama, S. Akao, K. Gotou, T. Fujiwara, and H. Fujiwara Induction of apoptosis by gallic acid in lung cancer cells Anticancer Drug 10 1999 845 851 (Pubitemid 30011832)
20. S. Di Giovanni, S. Eleuteri, K.E. Paleologou, G. Yin, M. Zweckstetter, P.A. Carrupt, and H.A. Lashuel Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity J. Biol. Chem. 285 2010 14941 14954
21. H. LeVine, L. Lampe, L. Abdelmoti, and C.E. Augelli-Szafran Dihydroxybenzoic acid isomers differentially dissociate soluble biotinyl-Abeta(1-42) oligomers Biochemistry 51 2012 307 315
22. Y. Liu, T.L. Pukala, I.F. Musgrave, D.M. Williams, F.C. Dehle, and J.A. Carver Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation Bioorg. Med. Chem. Lett. 23 2013 6336 6340
23. J.Y. Ban, H.T. Nguyen, H.J. Lee, S.O. Cho, H.S. Ju, J.Y. Kim, K. Bae, K.S. Song, and Y.H. Seong Neuroprotective properties of gallic acid from Sanguisorbae radix on amyloid beta protein (25-35)-induced toxicity in cultured rat cortical neurons Biol. Pharm. Bull. 31 2008 149 153
24. M. Pellecchia, D.S. Sem, and K. Wuthrich NMR in drug discovery Nat. Rev. Drug Discov. 1 2002 211 219 (Pubitemid 37361424)
25. D. Touboul, L. Maillard, A. Grasslin, R. Moumne, M. Seitz, J. Robinson, and R. Zenobi How to deal with weak interactions in noncovalent complexes analyzed by electrospray mass spectrometry: cyclopeptidic inhibitors of the nuclear receptor coactivator 1-STAT6 J. Am. Soc. Mass Spectrom. 20 2009 303 311
26. M.D. Leavell, S.P. Gaucher, J.A. Leary, J.A. Taraszka, and D.E. Clemmer Conformational studies of Zn-ligand-hexose diastereomers using ion mobility measurements and density functional theory calculations J. Am. Soc. Mass Spectrom. 13 2002 284 293 (Pubitemid 34552607)
27. R.E. Bornschein, S.J. Hyung, and B.T. Ruotolo Ion mobility-mass spectrometry reveals conformational changes in charge reduced multiprotein complexes J. Am. Soc. Mass Spectrom. 22 2011 1690 1698
28. K.A. Conway, J.D. Harper, and P.T. Lansbury Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nat. Med. 4 1998 1318 1320 (Pubitemid 28512115)
29. M.J. Volles, and P.T. Lansbury Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity J. Mol. Biol. 366 2007 1510 1522 (Pubitemid 46215614)
30. W.F. Vranken, W. Boucher, T.J. Stevens, R.H. Fogh, A. Pajon, M. Llinas, E.L. Ulrich, J.L. Markley, J. Ionides, and E.D. Laue The CCPN data model for NMR spectroscopy: development of a software pipeline Proteins 59 2005 687 696 (Pubitemid 40695845)
31. D. Eliezer, E. Kutluay, R. Bussell Jr., and G. Browne Conformational properties of alpha-synuclein in its free and lipid-associated states J. Mol. Biol. 307 2001 1061 1073 (Pubitemid 33029953)
32. L. Kang, M.K. Janowska, G.M. Moriarty, and J. Baum Mechanistic insight into the relationship between N-terminal acetylation of alpha-synuclein and fibril formation rates by NMR and fluorescence PLoS One 8 2013
33. H. LeVine Quantification of beta-sheet amyloid fibril structures with thioflavin T Methods Enzymol. 309 1999 274 284
34. W. Hoyer, T. Antony, D. Cherny, G. Heim, T.M. Jovin, and V. Subramaniam Dependence of alpha-synuclein aggregate morphology on solution conditions J. Mol. Biol. 322 2002 383 393
35. R.R. Abzalimov, A.K. Frimpong, and I.A. Kaltashov Detection and characterization of large-scale protein conformational transitions in solution using charge-state distribution analysis in ESI-MS Methods Mol. Biol. 896 2012 365 373
36. M. Sato, K. Murakami, M. Uno, Y. Nakagawa, S. Katayama, K. Akagi, Y. Masuda, K. Takegoshi, and K. Irie Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues J. Biol. Chem. 288 32 2013 23212 23224
37. J.L. Yao, X. Gao, W.L. Sun, T.M. Yao, S. Shi, and L.N. Ji Molecular hairpin: a possible model for inhibition of tau aggregation by tannic acid Biochemistry 52 2013 1893 1902
38. J.H. Lu, M.T. Ardah, S.S. Durairajan, L.F. Liu, L.X. Xie, W.F. Fong, M.Y. Hasan, J.D. Huang, O.M. El-Agnaf, and M. Li Baicalein inhibits formation of alpha-synuclein oligomers within living cells and prevents Abeta peptide fibrillation and oligomerisation Chembiochem 12 2011 615 624
39. X. Meng, L.A. Munishkina, A.L. Fink, and V.N. Uversky Molecular mechanisms underlying the flavonoid-induced inhibition of alpha-synuclein fibrillation Biochemistry 48 2009 8206 8224
40. P.H. Weinreb, W. Zhen, A.W. Poon, K.A. Conway, and P.T. Lansbury Jr. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded Biochemistry 35 1996 13709 13715 (Pubitemid 26363912)
41. V.N. Uversky, J.R. Gillespie, and A.L. Fink Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41 2000 415 427
42. V.N. Uversky, and A.L. Fink Conformational constraints for amyloid fibrillation: the importance of being unfolded Biochim. Biophys. Acta 1698 2004 131 153 (Pubitemid 38591469)
43. M.S. Celej, R. Sarroukh, E. Goormaghtigh, G.D. Fidelio, J.M. Ruysschaert, and V. Raussens Toxic prefibrillar alpha-synuclein amyloid oligomers adopt a distinctive antiparallel beta-sheet structure Biochem. J. 443 2012 719 726
44. G. Liu, A. Prabhakar, D. Aucoin, M. Simon, S. Sparks, K.J. Robbins, A. Sheen, S.A. Petty, and N.D. Lazo Mechanistic studies of peptide self-assembly: transient alpha-helices to stable beta-sheets J. Am. Chem. Soc. 132 2010 18223 18232
45. P. Taboada, S. Barbosa, E. Castro, and V. Mosquera Amyloid fibril formation and other aggregate species formed by human serum albumin association J. Phys. Chem. B 110 2006 20733 20736 (Pubitemid 44797322)
46. P. Sarni-Manchado, and V. Cheynier Study of non-covalent complexation between catechin derivatives and peptides by electrospray ionization mass spectrometry J. Mass Spectrom. 37 2002 609 616 (Pubitemid 34700470)
47. B.N. Pramanik, P.L. Bartner, U.A. Mirza, Y.H. Liu, and A.K. Ganguly Electrospray ionization mass spectrometry for the study of non-covalent complexes: an emerging technology J. Mass Spectrom. 33 1998 911 920 (Pubitemid 28499657)
48. N. Guo, R. Zhang, F. Song, J. He, B. Xia, and Z. Abliz Characterization of acid-induced protein conformational changes and noncovalent complexes in solution by using coldspray ionization mass spectrometry J. Am. Soc. Mass Spectrom. 20 2009 845 851
49. S.J. Eyles, T. Dresch, L.M. Gierasch, and I.A. Kaltashov Unfolding dynamics of a beta-sheet protein studied by mass spectrometry J. Mass Spectrom. 34 1999 1289 1295 (Pubitemid 30011528)
50. L. Konermann, and D.J. Douglas Equilibrium unfolding of proteins monitored by electrospray ionization mass spectrometry: distinguishing two-state from multi-state transitions Rapid Commun. Mass Spectrom. 12 1998 435 442 (Pubitemid 28181283)
51. A. Rekas, C.G. Adda, J. Andrew Aquilina, K.J. Barnham, M. Sunde, D. Galatis, N.A. Williamson, C.L. Masters, R.F. Anders, C.V. Robinson, R. Cappai, and J.A. Carver Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity J. Mol. Biol. 340 2004 1167 1183 (Pubitemid 38968709)
52. A. Abelein, L. Lang, C. Lendel, A. Graslund, and J. Danielsson Transient small molecule interactions kinetically modulate amyloid beta peptide self-assembly FEBS Lett. 586 2012 3991 3995
53. K.J. Binger, H. Ecroyd, S. Yang, J.A. Carver, G.J. Howlett, and M.D. Griffin Avoiding the oligomeric state: alphaB-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils FASEB J. 27 2013 1214 1222
54. G. Esposito, M. Garvey, V. Alverdi, F. Pettirossi, A. Corazza, F. Fogolari, M. Polano, P.P. Mangione, S. Giorgetti, M. Stoppini, A. Rekas, V. Bellotti, A.J. Heck, and J.A. Carver Monitoring the interaction between beta2-microglobulin and the molecular chaperone alphaB-crystallin by NMR and mass spectrometry: alphaB-crystallin dissociates beta2-microglobulin oligomers J. Biol. Chem. 288 2013 17844 17858